The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah ...

Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.

The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on limiting prescription drug prices goes against a federal program.

The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...

Pharmaceutical giant AstraZeneca is suing Utah’s attorney general and insurance commissioner over a law passed during the ...

Expanding hospital-based pharmacies may increase medication adherence, reduce hospital admissions, improve access and ...

AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law ...

Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

President Trump recently issued an executive order, aiming to lower prescription costs down for Americans by aligning prices ...

FDA’s recent focus on potentially harmful color additives in food products has expanded to the pharmaceutical sector. In May ...